The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and ...

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.

Eli Lilly briefly crossed the $1 trillion market cap threshold, the first drug maker to ever reach that milestone.

The world’s largest drugmaker, Eli Lilly & Co., just notched another milestone: it’s the first health-care company to cross ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly became the first drugmaker to reach a $1 trillion market valuation on Friday, driven by the rapid growth of its ...

Wall Street projects the global weight-loss drug market could reach $150 billion by 2030, with Lilly and Novo Nordisk ...

Eli Lilly becomes the first healthcare firm to hit $1T, powered by GLP-1 dominance, surging sales, and strong investor ...

Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo ...

Eli Lilly hit a $1 trillion valuation, driven by demand for Zepbound and Mounjaro. The first health-care firm ever to join ...

Eli Lilly’s stock reached an all-time high of 1057.42 USD, marking a significant milestone for the pharmaceutical giant with a market capitalization now exceeding $940 billion. Over the past year, the ...

Eli Lilly's stock has captured attention as consensus analyst price targets have risen from $919 to $1,003 per share. This ...